Published in PLoS One on April 11, 2012
Adenoma detection rate in 41,010 patients from Southwest China. Oncol Lett (2015) 0.93
Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective, nationwide survey. PLoS One (2013) 0.90
Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: clinical application. World J Gastroenterol (2014) 0.81
Gastric emptying evaluation by ultrasound prior colonoscopy: an easy tool following bowel preparation. World J Gastroenterol (2014) 0.79
Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence. BMC Gastroenterol (2014) 0.79
Age Is the Only Predictor of Poor Bowel Preparation in the Hospitalized Patient. Can J Gastroenterol Hepatol (2016) 0.75
Quality of colonoscopy in an emerging country: A prospective, multicentre study in Russia. United European Gastroenterol J (2016) 0.75
Phosphate tablets or polyethylene glycol for preparation to colonoscopy? A multicentre non-inferiority randomized controlled trial. Surg Endosc (2016) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50
Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA (2006) 6.26
Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc (2003) 5.52
Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology (2007) 5.30
Location of adenomas missed by optical colonoscopy. Ann Intern Med (2004) 4.95
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63
Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med (1997) 2.56
Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol (2006) 2.41
Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc (2000) 2.26
Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer (1986) 2.22
Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology (2004) 2.17
Interval cancers after negative colonoscopy: population-based case-control study. Gut (2011) 1.97
Quality assurance and colonoscopy. Endoscopy (1999) 1.65
Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy (2009) 1.56
A call to action--measuring the quality of colonoscopy. N Engl J Med (2006) 1.52
A comparison of optical colonoscopy and CT colonography screening strategies in the detection and recovery of subcentimeter adenomas. Am J Gastroenterol (2010) 1.49
Patients' description of rectal effluent and quality of bowel preparation at colonoscopy. Gastrointest Endosc (2010) 1.36
Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum (2008) 1.33
Colonic work-up after incomplete colonoscopy: significant new findings during follow-up. Endoscopy (2010) 1.16
Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroenterol (2010) 1.06
Split-dose bowel preparation for colonoscopy and residual gastric fluid volume: an observational study. Gastrointest Endosc (2010) 1.01
Adenoma detection rate and the quality of colonoscopy: the sword has two edges. Dis Colon Rectum (2008) 0.97
Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry (2010) 0.91
Variations in colonoscopy practice in Europe: a multicentre descriptive study (EPAGE). Scand J Gastroenterol (2007) 0.84
Quality control of colonoscopy procedures: a prospective validated method for the evaluation of professional practices applicable to all endoscopic units. Gastroenterol Clin Biol (2008) 0.84
Colonoscopy: a tarnished gold standard? Gastroenterology (2007) 0.80
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
Risk Factors for Aneurysm Recurrence: Response Radiology (2017) 5.28
Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2013) 4.03
Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology (2008) 3.15
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology (2003) 2.96
Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc (2010) 1.91
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One (2012) 1.53
[Appropiateness of colonoscopy in a gastrointestinal unit in 2001: a prospective study using criteria established by a European panel of experts]. Gastroenterol Clin Biol (2003) 1.44
Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res (2006) 1.44
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol (2008) 1.42
CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol (2003) 1.38
Calcium supplementation for preventing colorectal cancer: where do we stand? Lancet (2004) 1.38
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology (2005) 1.33
Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR. J Clin Microbiol (2003) 1.23
Pancreatic metastases: a multicentric study of 22 patients. Gastroenterol Clin Biol (2004) 1.18
From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma. BMC Genomics (2010) 1.16
High resolution colonoscopy with chromoscopy versus standard colonoscopy for the detection of colonic neoplasia: a randomized study. Clin Gastroenterol Hepatol (2006) 1.15
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 1.14
Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther (2012) 1.13
Endoscopic submucosal dissection: the best way to deal with subsquamous metaplasia? Endoscopy (2015) 1.06
Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib. Invest New Drugs (2010) 1.05
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter study. Gastrointest Endosc (2010) 1.04
High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter (2010) 1.04
Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology (2012) 1.00
Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest (2008) 1.00
Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma. J Pathol (2003) 1.00
Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol (2007) 0.98
Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. Gut (2010) 0.95
Early experience with a novel hemostatic powder used to treat upper GI bleeding related to malignancies or after therapeutic interventions (with videos). Gastrointest Endosc (2013) 0.94
Helpfulness of the combination of acetic acid and FICE in the detection of Barrett's epithelium and Barrett's associated neoplasias. World J Gastroenterol (2012) 0.94
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib. PLoS One (2011) 0.92
A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol (2007) 0.91
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Gastroenterology (2009) 0.90
Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective, nationwide survey. PLoS One (2013) 0.90
Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology (2004) 0.90
Portal hypertensive duodenal polyp: a case report. World J Gastroenterol (2007) 0.90
Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial. Gut (2011) 0.90
Chronic rectal ulcer as result of combined mucosal toxicity of NSAID, argon plasma coagulation and radiotherapy. Dig Liver Dis (2011) 0.90
Functional results after laparoscopic Heller myotomy for achalasia: A comparative study to open surgery. Surgery (2004) 0.90
Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci (2003) 0.89
Obscure bleeding colonic duplication responds to proton pump inhibitor therapy. World J Gastroenterol (2013) 0.89
The complementary Erlangen active simulator for interventional endoscopy training is superior to solely clinical education in endoscopic hemostasis--the French training project: a prospective trial. Eur J Gastroenterol Hepatol (2006) 0.89
Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm Bowel Dis (2004) 0.89
Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int J STD AIDS (2008) 0.88
Iron deficiency: from diagnosis to treatment. Dig Liver Dis (2013) 0.88
Risk factors for advanced adenomas amongst small and diminutive colorectal polyps: a prospective monocenter study. Dig Liver Dis (2011) 0.88
Pancreatic metastasis from prostate cancer. Case Rep Med (2010) 0.87
The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab. Anticancer Drugs (2014) 0.87
Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat. Eur J Pharmacol (2007) 0.87
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment. Dig Liver Dis (2011) 0.86
Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies. Med Oncol (2013) 0.86
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. Med Oncol (2012) 0.86
First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohn's disease. Inflamm Bowel Dis (2011) 0.85
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J (2007) 0.85
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. Dig Liver Dis (2012) 0.84
Sarcoidosis lung nodules in colorectal cancer follow-up: sarcoidosis or not? Am J Med (2013) 0.84
Gastric polyp prolapsed into the duodenum as a rare cause of acute pancreatitis. Ann R Coll Surg Engl (2010) 0.84
Endoscopic management of post-laparoscopic cholecystectomy biliary strictures. Long-term outcome in a multicenter study. Gastroenterol Clin Biol (2006) 0.84
Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer. Curr Top Med Chem (2005) 0.83
Cancers of the biliary system. Gastroenterol Clin Biol (2006) 0.82
Helicobacter pylori and non-malignant diseases. Helicobacter (2006) 0.82
Endoscopic treatment of biliary fistulas after complex liver resection. Ann Surg (2011) 0.82
Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis. Oncology (2012) 0.81
N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model. Fibrogenesis Tissue Repair (2012) 0.81
[Patient-doctor relationship in the irritable bowel syndrome. Results of a French prospective study on the influence of the functional origin of the complaints]. Gastroenterol Clin Biol (2002) 0.81
A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 0.81
[Acute cytolysis induced by Chinese tea]. Gastroenterol Clin Biol (2002) 0.81
[Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study]. Gastroenterol Clin Biol (2002) 0.81
[Conservative management of esophageal perforation after pneumatic dilatation for achalasia]. Gastroenterol Clin Biol (2002) 0.81
A prospective national study on colonoscopy and sigmoidoscopy in 2000 in France. Gastroenterol Clin Biol (2005) 0.80
Synthesis of enantiomerically pure D-FDOC, an anti-HIV agent. Bioorg Med Chem Lett (2004) 0.80
Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients. Invest New Drugs (2010) 0.80
CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant (2008) 0.80
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation (2004) 0.80
Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. Rheumatology (Oxford) (2011) 0.80
Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol (2009) 0.80
[Hepatic abscess from Clostridium perfringens septicemia]. Gastroenterol Clin Biol (2003) 0.80